Article

Effectors and potential targets selectively upregulated in human KRAS-mutant lung adenocarcinomas

2016-02-23

Abstract excerpt

Genetic and proteomic analysis of human tumor samples can provide an important compliment to information obtained from model systems. Here we examined protein and gene expression from the Cancer Genome and Proteome Atlases (TCGA and TCPA) to characterize proteins and protein-coding genes that are selectively upregulated in KRAS -mutant lung adenocarcinomas. Phosphoprotein activation of several MAPK signaling comp...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fcb51430-1158-50d7-a5a7-6c82556aa7b4
DOI: 10.1101/041137

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Effectors and potential targets selectively upregulated in human KRAS-mutant lung adenocarcinomasDOI 10.1101/041137Read

Effectors and potential targets selectively upregulated in human KRAS-mutant lung adenocarcinomas.Semantic proximity Read

Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors.Semantic proximity Read

Identification of subsets of actionable genetic alterations in KRAS-mutant lung cancers using association rule mining.Semantic proximity Read

Wild-Type KRAS Allele Effects on Druggable Targets in KRAS Mutant Lung Adenocarcinomas.Semantic proximity Read

Identification of Subsets of Genetic Alterations in KRAS-mutant Lung Cancer using Association Rule MiningSemantic proximity Read

Phosphoproteomics Identifies Oncogenic Ras Signaling Targets and Their Involvement in Lung AdenocarcinomasSemantic proximity Read

Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer.Semantic proximity Read

KRAS-Mutant Lung Cancers in the Era of Targeted Therapy.Semantic proximity Read

Gene expression profiling of epidermal growth factor receptor/KRAS pathway activation in lung adenocarcinoma.Semantic proximity Read

Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities.Semantic proximity Read

ERK-dependent protein phosphorylation in KRAS-mutant cancer: a mix of the expected and surprising.Semantic proximity Read

Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers.Semantic proximity Read